Ping Yan

3.7k citations
55 papers · 2.3k indexed · 1 hit paper · h-index 21

Impact in

Papers in

Ping Yan

53 papers receiving 2.2k citations

Hit Papers

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial 2010 · 510 citations
5102010202620152020100200300400500

Peers

Ping Yan
Comparison fields: 5 of 121
  • Endocrinology, Diabetes and Metabolism 1.3k
  • Nephrology 237
  • Pharmacology 343
  • Surgery 601
  • Family Practice 27
Replace Riccardo Candido with:
Riccardo Candido Italy
Lennart Tonneijck Netherlands
Samy Hadjadj France
Egon Pfarr Germany
Marcel H.A. Muskiet Netherlands
Hideki Kishikawa Japan
Remo H.M. Furtado Brazil
Thomas Meinicke Germany
Stephen D. Wiviott United States
Hideaki Jinnouchi Japan
Ping Yan relative to Riccardo Candido Italy Riccardo Candido's profile →
Citations per field
00.5×1.5×2.5×
Riccardo Candido · 1×
Citations per year

Countries citing papers authored by Ping Yan

Since Specialization
Citations

This map shows the geographic impact of Ping Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Yan more than expected).

Fields of papers citing papers by Ping Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Yan. The network helps show where Ping Yan may publish in the future.

Co-authors

The 25 scholars most cited alongside Ping Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ping Yan Line = papers co-authored together Ping Yan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
Hit paper breakdown →
2010510
2 2011373
3 2014166
4 2010117
5 2010116
6 2011101
7 202097
8 202060
9 201450
10 201249
11 201147
12 202044
13 201941
14 202139
15 201036
16 202327
17 202026
18 202224
19 202024
20 202223

About Ping Yan

Ping Yan is a scholar working on Nephrology, Critical Care and Intensive Care Medicine, Endocrinology, Diabetes and Metabolism, Family Practice and Emergency Medicine, having authored 55 papers that have together received 2.3k indexed citations. Recurring topics across this work include Acute Kidney Injury Research (20 papers), Diabetes Treatment and Management (8 papers), Chronic Kidney Disease and Diabetes (8 papers), Diabetes Management and Research (6 papers), Metabolism, Diabetes, and Cancer (6 papers), Dialysis and Renal Disease Management (6 papers), Hemodynamic Monitoring and Therapy (5 papers) and Blood Pressure and Hypertension Studies (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.3k citations), Nephrology (237 citations), Pharmacology (343 citations), Surgery (601 citations) and Family Practice (27 citations). Ping Yan has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jaret Malloy, Richard M. Bergenstal, Brandon Walsh, Carol Wysham, Leigh MacConell, Lisa E. Porter, Ken Wilhelm, Thomas Blevins, Kristin Taylor and John Pullman. Their work appears in journals such as Scientific Reports, Renal Failure, European Radiology, Journal of Clinical Oncology and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026